FloraWorks
PrivateLast Round
Series A
Jun 22, 2023
Total Funding Raised
$2.25M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
FloraWorks operates in Healthcare & Life Sciences and is based in Portland, Oregon. Its latest recorded funding round was a Series A round in June 2023.
FloraWorks is a biotechnology company that develops and supplies hemp-derived cannabinoid ingredients for use in consumer and healthcare applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Quality Management
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FloraWorks Comparables
Compare FloraWorks with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sanobiotec | 86% | |
| Red Mesa Science & Refining | 83% | |
| Mile High Labs | 81% |
For institutional investors. Book with your work email.
FloraWorks Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
FloraWorks Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Arcview Group | Series A |
| Bonaventure Equity | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors increased 60% MoM, reaching 12.4K.
- Aug 21, 2026
Monthly visitors increased 419% MoM, reaching 7.8K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventOct 27, 2026
FloraWorks Holdings Inc. is set to make a significant presentation at the Global Cannabinoid Research Society Conference, showcasing its contributions to cannabinoid research.
- hiresOct 27, 2026
FloraWorks Holdings Inc. appoints Dr. Matthew Roberts as Chief Operating Officer to oversee operations including supply chain management, production, quality assurance, and regulatory affairs.
- expands_facilitiesOct 27, 2026
In 2020, FloraWorks Holdings Inc. expands its physical facilities with the first commercial-scale CBN isolate manufacturing facility in Oregon.
- partners_withOct 27, 2026
FloraWorks Holdings Inc. and Salk collaborate to study how cannabinoids protect aging neuronal cells and may help mitigate age-related neurodegeneration.
For institutional investors. Book with your work email.
FloraWorks Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about FloraWorks's valuation, stock price, and market status.
Is FloraWorks a public or private company?
FloraWorks is a private company.
What is the current stock price of FloraWorks?
FloraWorks is a private company, so its shares have no public market price. Caplight tracks FloraWorks's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is FloraWorks worth (valuation)?
Valuation information for FloraWorks is not publicly available.
Can I buy FloraWorks stock?
FloraWorks shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was FloraWorks's last funding round?
FloraWorks's most recent funding round was Series A on June 22, 2023.
Who are the main investors in FloraWorks?
Key investors in FloraWorks include Bonaventure Equity.
Will FloraWorks IPO soon?
No public IPO plans have been announced for FloraWorks.
How can I track FloraWorks secondary market activity?
Caplight tracks bids, offers, and trades in FloraWorks's shares on secondary markets.